LANDMARK STUDY: AUTISM RECOGNIZED AS MEDICALLY TREATABLE

[Guest guest]

LANDMARK STUDY: AUTISM RECOGNIZED AS MEDICALLY TREATABLE

PRESS RELEASE CONTACTS:

For Immediate Release

CoMeD President [Rev. K. Sykes (Richmond, VA) ]

December 5, 2008

CoMeD Sci. Advisor [Dr. King (Lake Hiawatha, NJ) ]

>

>WASHINGTON, DC - In April of 2008, the American College

>of Medical Genetics (ACMG), an AMA-recognized board,

>issued clinical practice guidelines that clinical

>geneticists should follow in determining the etiology

>for those with an autistic spectrum disorder (ASD)

>diagnosis and in treating patients with this diagnosis.

>This study, " Autism spectrum disorder-associated

>biomarkers for case evaluation and management by

>clinical geneticists " in Expert Review of Molecular

>Diagnostics, [1] confirms that there are now well-estab-

>lished, routine, clinically available, identified

>biomarkers to help clinical geneticists medically

>evaluate and treat individuals diagnosed with an ASD

>and briefly outlines some recognized biomarkers.

>Depending on the cause of the ASD, these researchers

>have found that " associated medical risks may be

>identified, which may lead to screening and poten-

>tial morbidity prevention in patients and other

>family members. " The non-profit CoMeD, Inc., and,

>through a grant from the Brenen Hornstein Autism

>Research & Education (BHARE) Foundation, the non-

>profit Institute of Chronic Illnesses, Inc. funded

>this research study.

>

>The important clinical tools identified for medical

>evaluation and treatment response monitoring included:

>

>q Pophyrin biomarkers - to help determine if mercury

> toxicity is present, and, when it is found, to

> monitor changes in mercury-burden during detoxifi-

> cation therapies.

>

>q Trans-Sulfuration biomarkers - to help determine

> if mercury biochemical susceptibility is present

> and, when it is found, to monitor patient response

> during supplementation with nutritional therapies

> such as methylcobalamin (the methyl form of vita-

> min B12), folinic acid, and pyroxidine (vitamin B6).

>

>q Oxidative Stress/Inflammation biomarkers - to help

> determine if there are excessive by-products of

> metabolic pathways, and, when they are found, to

> monitor patient progress during supplementation

> with anti-inflammatory drugs such as Aldactone®

> (spironolactone) .

>

>q Hormonal biomarkers - to help determine if hormonal

> abnormalities are present and, when they are found,

> to monitor patient progress during the indicated

> treatment with hormonal regulation drugs such as

> Lupron® (leuprolide acetate) and Yaz® (drospirenone/

> ethynyl estradiol).

>q Mitochondrial Dysfunction biomarkers - to help de-

> termine if there are disruptions in the energy pro-

> duction pathways, and, when they are found, to

> monitor patient progress during supplementation

> with drugs such as Carnitor® (L-carnitine) .

>

>q Genetic biomarkers - to help determine if there

> are genetic causal or susceptibility factors

> present, and, when they are found, to provide

> insights into behavior modification to help re-

> duce the impact of such genetic factors.

>

>Today, any parent, physician, or healthcare provi-

>der can easily engage the services of a clinical

>geneticist who is following the ACMG practice

>guidelines to help evaluate and treat those diag-

>nosed with an ASD by contacting ASD Clinics, LLC,

>a national outreach clinic helping to provide

>clinical genetic services through the Genetic

>Centers of America. For information about sched-

>uling a consultation, please call .

>

>Current Consultation Center Locations:

>West Coast - Genetic Consultants of Washington

> State (Seattle, WA)

>Central - Genetic Consultants of Indianapolis

> (Indianapolis, IN)

>East Coast - Genetic Consultants of land

> (Washington, DC)

>

>ENDNOTE

>[1] Geier Da, Geier MR. Expert. Rev. Mol. Diagn. 2008;

> 8(6): 671-674.

>

Hopefully, most will find this

Press Release to be informative.

************ ********* ********* ********* ****

*The information provided in this email *

*and any attachment thereto is just that *

* -- information. *

* *

*It is not medical advice and it does not *

*require any specific action or actions. *

* *

*While the information is thought to be *

*accurate, no representation is made as *

*to the accuracy of the information posted*

*other than it is my best understanding of*

*the facts on the date that this email and*

*any attachments thereto are posted. *

* *

*Everyone should verify the accuracy of *

*the information provided for themselves *

*before acting on it. *

************ ********* ********* ********* ****

Respectfully,

Dr. King

http://www.dr- king.com